Managing heavy menstrual bleeding in adolescents with hormonal treatments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of hormonal medications, such as contraceptive pills, patches, injectable progestins, and hormonal intra-uterine devices, in managing heavy menstrual bleeding among adolescents with and without bleeding disorders. Participants will undergo assessments including questionnaires and blood tests to monitor hemoglobin and iron levels, as well as quality of life. The study will follow participants for one year to compare outcomes between those with bleeding disorders and those without.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adolescents and young adults aged \< 26yo
* Presenting to the gynecology consultation at HUG
* Diagnosed with heavy menstrual bleeding (PBAC \> 100)
* Willing to initiate a hormonal medication to manage heavy menstrual bleeding

Exclusion Criteria:

* Pregnancy or planning to become pregnant during the study period
* Already using hormonal medication for menstrual management and/or contraception
* Known anatomical uterine pathology
* Using anticoagulant or antiaggregant agents

Where it's running

• Geneva University Hospitals
  Geneva, Switzerland Recruiting

Study contacts

• Study coordinator: Dehlia Moussaoui, MD
• Email: dehlia.moussaoui@hug.ch
• Phone: +41 22 372 33 87

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Progestin options for heavy periods in young people with inherited bleeding disorders

  This project will test two progestin menstrual treatments—a levonorgestrel IUD and daily norethindrone acetate—in adolescents and young adults (ages 10–24) with inherited bleeding disorders to see which better reduces heavy menstrual bleeding over six months.

  Recruiting at 6 sites Oregon Health and Science University · Palo Alto, California and 7 other locations · NCT05916469

• Mother-and-child hemophilia A program

  See if following pregnant people with a severe hemophilia A genotype and their children from pregnancy through early childhood can identify factors linked to maternal bleeding and the child’s development of anti‑FVIII antibodies.

  Recruiting University of Washington · Seattle, Washington · NCT07414511

• tAN to reduce heavy menstrual bleeding (LUNA)

  This trial tests whether transcutaneous auricular neurostimulation (tAN) can reduce heavy menstrual bleeding in people aged 14–45 with no known structural cause.

  Recruiting Spark Biomedical, Inc. · Boston, Massachusetts · NCT07326722

• ATHNdataset registry for people with bleeding and clotting disorders

  This registry collects health, treatment, and patient-reported information from people with bleeding and clotting disorders seen at ATHN-affiliated centers to help improve care and outcomes.

  Recruiting American Thrombosis and Hemostasis Network · Hickory, North Carolina · NCT06820515

• Early genomic testing to find inherited causes of bleeding

  This project will test whether doing genomic testing early helps people referred to hematology with suspected inherited bleeding disorders get diagnosed sooner and more often.

  Recruiting at 2 sites Early Phase 1 Queen's University · Kingston, Ontario and 2 other locations · NCT06736158

• Observational study of blood clotting and bleeding disorders in Chinese patients

  This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality and 4 other locations · NCT06727669

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.